AORT

Artivion (AORT)

About Artivion (AORT)

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.

Details

Daily high
$28.83
Daily low
$27.86
Price at open
$27.72
52 Week High
$30.45
52 Week Low
$16.48
Market cap
1.2B
Dividend yield
0.00%
Volume
959,011
Avg. volume
287,868
P/E ratio
-1,103.88

Artivion News

Details

Daily high
$28.83
Daily low
$27.86
Price at open
$27.72
52 Week High
$30.45
52 Week Low
$16.48
Market cap
1.2B
Dividend yield
0.00%
Volume
959,011
Avg. volume
287,868
P/E ratio
-1,103.88